Combined Therapy with Renin-Angiotensin System and Calcium Channel Blockers in Type 2 Diabetic Hypertensive Patients with Proteinuria: Effects on Soluble TWEAK, PTX3, and Flow-Mediated Dilation-Reference-Cited by-同舟云学术

Combined Therapy with Renin-Angiotensin System and Calcium Channel Blockers in Type 2 Diabetic Hypertensive Patients with Proteinuria: Effects on Soluble TWEAK, PTX3, and Flow-Mediated Dilation

Published:2010-04-29 Issue:7 Volume:5 Page:1174-1181
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Yilmaz Mahmut Ilker,Carrero Juan Jesús,Martín-Ventura Jose Luis,Sonmez Alper,Saglam Mutlu,Celik Turgay,Yaman Halil,Yenicesu Mujdat,Eyileten Tayfun,Moreno Juan Antonio,Egido Jesús,Blanco-Colio Luis Miguel

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference46 articles.

1. Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis

2. Endothelial Dysfunction

3. Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?

4. Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials

5. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection;Locatelli;Kidney Int Suppl,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentraxin 3: A promising therapeutic target for cardiovascular diseases;Ageing Research Reviews;2024-01

2. Endothelial Dysfunction in Type 2 Diabetes with an Update on New Interventions;Contemporary Diabetes;2023

3. TWEAK–Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome;The Journal of Pathology;2021-03-10

4. The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study;Scientific Reports;2020-06-02

5. Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy;International Journal of Molecular Sciences;2020-05-27